RxDoctor Payments DataLook up a doctor →

Guillermo Garcia-Manero, MD

Medical Oncology · Houston, TXNPI 1013078294

Payments from drug & device makers

$31,556,766in general payments, 2019–2025

Across 1,006 payments — averaging $31,369 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$18.3M
  • Otsuka Pharmaceutical Co., Ltd.$3.1M
  • Merck$2.8M
  • Rigel Pharmaceuticals, Inc.$2.3M
  • Taiho Oncology, Inc.$1.7M
  • Bristol Myers Squibb$791K
  • plus $2.5M from 34 others
$21,561in research payments, 2019–2025

Across 16 payments — averaging $1347.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$12K
  • Servier Bioinnovation$4K
  • AbbVie$3K
  • Novartis$2K
  • Amgen$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$31,556,766 in reported general payments places this provider in the 95th percentile of 495 medical oncology providers in Texas.

See all medical oncology providers in Texas

Medicare billing

Part B allowed, 2024
$116,380
Medicare patients
207
Services billed
1,170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →